Cite
MLA Citation
G. Gregory et al.. “ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE‐155 STUDY.” Hematological oncology, vol. 37, n.d., pp. 328–329. http://access.bl.uk/ark:/81055/vdc_100086191805.0x00003b